These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3778943)

  • 1. Separation of inhibitory activity from biologically active parathyroid hormone in patients with pseudohypoparathyroidism type I.
    Loveridge N; Tschopp F; Born W; Devogelaer JP; Nagant de Deuxchaisnes C; Fischer JA
    Biochim Biophys Acta; 1986 Nov; 889(2):117-22. PubMed ID: 3778943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type I.
    de Deuxchaisnes CN; Fischer JA; Dambacher MA; Devogelaer JP; Arber CE; Zanelli JM; Parsons JA; Loveridge N; Bitensky L; Chayen J
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1105-9. PubMed ID: 7298795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of parathyroid hormone inhibitory activity of plasma in pseudohypoparathyroidism type I by i.v. calcium.
    Loveridge N; Fischer JA; Devogelaer JP; Nagant de Deuxchaisnes C
    Clin Endocrinol (Oxf); 1986 May; 24(5):549-54. PubMed ID: 3791650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metatarsal cytochemical bioassay of parathyroid hormone: validation, specificity, and application to the study of pseudohypoparathyroidism type I.
    Bradbeer JN; Dunham J; Fischer JA; Nagant de Deuxchaisnes C; Loveridge N
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1237-43. PubMed ID: 3192680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cytochemical bioactivity of parathyroid hormone by plasma in pseudohypoparathyroidism type I.
    Loveridge N; Fischer JA; Nagant de Deuxchaisnes C; Dambacher MA; Tschopp F; Werder E; Devogelaer JP; de Meyer R; Bitensky L; Chayen J
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1274-5. PubMed ID: 7076801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of circulating parathyroid hormone in pseudohypoparathyroidism.
    Mitchell J; Goltzman D
    J Clin Endocrinol Metab; 1985 Aug; 61(2):328-34. PubMed ID: 4008609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the biological activity of parathyroid hormone in pseudohypoparathyroidism: comparison with vitamin D deficiency.
    Allgrove J; Chayen J; Jayaweera P; O'Riordan JL
    Clin Endocrinol (Oxf); 1984 May; 20(5):503-14. PubMed ID: 6744632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism.
    Neer RM; Tregear GW; Potts JT
    J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.
    Kruse K; Kracht U
    Eur J Pediatr; 1987 Jul; 146(4):373-7. PubMed ID: 2820733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
    Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
    Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of parathyroid hormone (1-84) whole molecule and parathyroid hormone (7-84)-like fragments in pseudohypoparathyroidism type I.
    Hatakeyama Y; Mizunashi K; Furukawa Y; Yabuki S; Sato Y; Igarashi T
    J Clin Endocrinol Metab; 2003 May; 88(5):2250-5. PubMed ID: 12727982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum intact parathyroid hormone concentration measured by a two-site immunoradiometric assay in normal subjects and patients with various parathyroid disorders.
    Okazaki R; Matsumoto T; Furukawa Y; Fujimoto Y; Niimi H; Seino Y; Fujita T; Nagataki S; Ogata E
    Endocrinol Jpn; 1992 Feb; 39(1):115-20. PubMed ID: 1606913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adenylate cyclase bioassay for parathyroid hormone: some clinical experiences.
    Seshadri MS; Chan YL; Wilkinson MR; Mason RS; Posen S
    Clin Sci (Lond); 1985 Mar; 68(3):321-6. PubMed ID: 3971662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism.
    Mallette LE; Kirkland JL; Gagel RF; Law WM; Heath H
    J Clin Endocrinol Metab; 1988 Nov; 67(5):964-72. PubMed ID: 2846629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of circulating parathyroid hormone in man by a homologous amino-terminal specific radioimmunoassay.
    Konagaya Y; Konagaya M; Takatsuki K; Tomita A; Watanabe S; Noda T; Katsuragi S
    Jpn J Med; 1984 Aug; 23(3):199-204. PubMed ID: 6492483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K; Furukawa Y; Miura R; Yumita S; Sohn HE; Yoshinaga K
    J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
    Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
    J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin and calcitonin responses to parathyroid hormone infusion in hypoparathyroid, pseudohypoparathyroid, and normal subjects.
    Brickman AS; Carlson HE; Deftos LJ
    J Clin Endocrinol Metab; 1981 Sep; 53(3):661-4. PubMed ID: 7263847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The administration of an active vitamin D(3) analogue reduced the serum concentrations of 1-84 and truncated parathyroid hormone in pseudohypoparathyroidism type Ib patients.
    Ishii A; Imanishi Y; Kurajoh M; Nagata Y; Kobayashi K; Miki T; Inaba M; Nishizawa Y
    Endocr J; 2010; 57(7):609-14. PubMed ID: 20508384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of circulating parathyroid hormone in man using a homologous amino-terminal specific immunoradiometric assay.
    Papapoulos SE; Manning RM; Hendy GN; Lewin IG; O'Riordan JL
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):57-67. PubMed ID: 7438464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.